Lymphomatoid granulomatosis treated with rituximab and chemotherapy.

Clinical advances in hematology & oncology : H&O

Volumn 1, Issue 11, 2003, Pages

  Rao, Ruta ^a   Vugman, Galina ^a   Leslie, William T ^a   Loew, Jerome ^a   Venugopal, Parameswaran ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD20 ANTIGEN; CHOP PROTOCOL; CYCLOPHOSPHAMIDE; DOXORUBICIN; METHOTREXATE; MONOCLONAL ANTIBODY; PREDNISONE; RITUXIMAB; TUMOR ANTIGEN; VINCRISTINE;

ADULT; ARTICLE; BRAIN CORTEX; BRAIN TUMOR; CASE REPORT; CHEMISTRY; EPSTEIN BARR VIRUS; GRAND MAL EPILEPSY; HUMAN; IMMUNOTHERAPY; ISOLATION AND PURIFICATION; LUNG TUMOR; LYMPHOMATOID GRANULOMATOSIS; MALE; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; REMISSION; SKULL IRRADIATION; VIROLOGY; VIRUS INFECTION; VISUAL DISORDER;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD20; ANTIGENS, NEOPLASM; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CEREBRAL CORTEX; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPILEPSY, TONIC-CLONIC; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOTHERAPY; LUNG NEOPLASMS; LYMPHOMATOID GRANULOMATOSIS; MAGNETIC RESONANCE IMAGING; MALE; METHOTREXATE; PREDNISONE; REMISSION INDUCTION; VINCRISTINE; VISION DISORDERS;

EID: 33744950072     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)